• Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis

    Nov 1, 2013, 00:00

  • Evaluating Overall Survival in Oncology Trials with Subsequent Therapies- A Methodological Review and Application in Non-Small Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System

    Nov 1, 2013, 00:00

  • Patients at the Center of Regulatory Decisions- Using Stated-Preference Data to Help Regulators Answer Difficult Questions

    Nov 1, 2013, 00:00

  • Medication Adherence and Adverse Health Outcomes in Community Dwelling Older Patients

    Nov 1, 2013, 00:00

  • EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Medication Errors-Incidence, Causes and Possible Prevention Strategies in Indian Health Care Setting

    Nov 1, 2013, 00:00

  • Comparison of Elderly Adults by Number of Rx Medications Used- Results from the National Health and Wellness Survey Across 5EU Countries

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- Methods Used in Recent Economic Evaluations

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

    Nov 1, 2013, 00:00

  • Modeling Medication Adherence in Comparative Effectiveness Research

    Nov 1, 2013, 00:00

  • Health Economics Assessment of the Cnamts Sophia Diabetic Patient Support Programme- Results of the First 4 Years

    Nov 1, 2013, 00:00

  • Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective

    Nov 1, 2013, 00:00

  • Anticoagulation Treatment with VKA in France, Italy, Germany, Spain and United Kingdom. Results from the React AF Study

    Nov 1, 2013, 00:00

  • Study of Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Symptom Assessment Differences Between Patients and Family Members

    Nov 1, 2013, 00:00

  • Would a New Therapy for Children Be Refused in the Context of the German Amnog?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC- A Payer Perspective in the United Kingdom

    Nov 1, 2013, 00:00

  • A Low Antiviral Treatment Rate in Chronic Heptitis C Patients in Taiwan- A Nationwide Physician-Based Survey

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Feasibility of Medicines Review to Reduce Potentially Inappropriate Medicines in the Elderly- The OPTI-SCRIPT Cluster Randomized Controlled Trial

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 Mcg for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

    Nov 1, 2013, 00:00

  • Prevalence of Risk Factors of St Elevated Myocardial Infarction

    Nov 1, 2013, 00:00

  • Costs of Management of Pregnancy in Obese Women Across Europe- The Dali Experience

    Nov 1, 2013, 00:00

  • Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin

    Nov 1, 2013, 00:00

  • Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

    Nov 1, 2013, 00:00

  • A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United States

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Cost of Illness Study

    Nov 1, 2013, 00:00

  • The Relationship Between Asthma-Specific Quality of Life and Measures of Asthma Control and Generic Quality of Life

    Nov 1, 2013, 00:00

  • Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians

    Nov 1, 2013, 00:00

  • The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Program

    Nov 1, 2013, 00:00

  • StratafixTM Knotless Tissue Control Devi A Budget Impact Analysis from Italian Health Service Perspective

    Nov 1, 2013, 00:00

  • Using Rasch Analysis to Co-Calibrate Scores from Outcome Measures Specific to Asthma (ALIS), Chronic Obstructive Pulmonary Disease (LCOPD) and Pulmonary Hypertension (CAMPHOR)

    Nov 1, 2013, 00:00

  • Assessing the Significance of HbA1c Durability in Cost Effectiveness Analysis of 2nd Line Oral Therapies in the Management of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Classification of Cognitive Dysfunction and Cognitive Normal Using Scores from Four Cognitive Assessments in Patients with Depressive Disorder

    Nov 1, 2013, 00:00

  • Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study

    Nov 1, 2013, 00:00

  • The Value of Pilot Testing Pro Symptom Diaries Prior to Conducting Cognitive Debriefing Interviews in Children/Adolescents- Qualitative and Quantitative Insights

    Nov 1, 2013, 00:00

  • Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin

    Nov 1, 2013, 00:00

  • Reduction in NSAIDS Consumption After Viscosupplementation with HA- Is It Costs Saving?

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in the United Kingdom

    Nov 1, 2013, 00:00

  • Determinantes De Los Costos De Accidentes De Tránsito Ocurridos En Medellín (Colombia) 2009-2010

    Nov 1, 2013, 00:00

  • Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy- Cost Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan Children

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones Clínicas Mucocutáneas De La Enfermedad De Behcet

    Nov 1, 2013, 00:00

  • Patient-Level Costs of Cardiovascular Events and Procedures- How Robust Is the Evidence?

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in Ukraine

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Anti-Oxidant Vitamin + Zinc Treatment to Prevent the Progression of Intermediate Age Related Macular Degeneration to Its Wet Form. A Singapore Perspective

    Nov 1, 2013, 00:00

  • Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En Reumatología- Uso De Los Estudios Económicos

    Nov 1, 2013, 00:00

  • Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis- 48-Week Results from the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa Rica

    Nov 1, 2013, 00:00

  • Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment

    Nov 1, 2013, 00:00

  • A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)

    Nov 1, 2013, 00:00

  • Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation Systems

    Nov 1, 2013, 00:00

  • Racial Disparities in Diffusion, Comparative Morbidity, and Disease Control of Intensity-Modulated Radiation Therapy Compared to Conformal Radiation Therapy for Localized Prostate Cancer

    Nov 1, 2013, 00:00

  • Health Outcomes at 6 to 120 Months Since Heart Transplant in Spain- Clinical Status, Health Related-Quality of Life and Utility Assessment

    Nov 1, 2013, 00:00

  • Acute Exposure of Bisphenol-A from Electronic Gadgets Does Not Induce Oxidative Stress in the Rat Brain

    Nov 1, 2013, 00:00

  • Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis

    Nov 1, 2013, 00:00

  • The Role of Communication and Health Literacy on Patient Safety in Public Pharmacies in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Treatments of Type 2 Diabetes Mellitus (T2DM)- A Systematic Review (Slr)

    Nov 1, 2013, 00:00

  • Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia C ...

    Nov 1, 2013, 00:00

  • Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units

    Nov 1, 2013, 00:00

  • The Efficiency of Preoperative Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease Undergoing Open Heart Surgery

    Nov 1, 2013, 00:00

  • Differences in Approach to Biosimilars- Nice Versus SMC Recommendations

    Nov 1, 2013, 00:00

  • Utility Values Used in National Institute for Health and Care Excellence (NICE) Technology Appraisals of Medicines for 4 Metastatic Cancers

    Nov 1, 2013, 00:00

  • Efectividad Y Costo-Efectividad De La Fluoración Del Agua En La Prevención De Caries Dental

    Nov 1, 2013, 00:00

  • Instructions for Authors

    Nov 1, 2013, 00:00

  • Direct and Indirect Burden Associated with Parents Whose Infant Has Been Hospitalized for a Lower Respiratory Tract Infection (LRTI) in Greece

    Nov 1, 2013, 00:00

  • Patient Satisfaction with HIV Therapies- Focus on Adherence to Treatment

    Nov 1, 2013, 00:00

  • The Effect of Medical Devices with Dose-Memory and Reminder Functions on Patients’ Treatment Adherence, Confidence and Disease Self-management

    Nov 1, 2013, 00:00

  • Factors Associated with Early Response to Olanzapine and Clinical and Functional Outcomes of Early Responders Treated for Schizophrenia in China

    Nov 1, 2013, 00:00

  • Causal Analysis of Longitudinal Patient Turnover Data at Hepatitis-C

    Nov 1, 2013, 00:00

  • The Cost of Treating Squamous Cell Carcinoma of the Anus (SCCA) in England- Results from an Empirically Calibrated Model

    Nov 1, 2013, 00:00

  • Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

    Nov 1, 2013, 00:00

  • DETERMINING THE MAGNITUDE OF A DETECTABLE AND A RELEVANT TREATMENT BENEFIT IN AESTHETIC MEDICINE USING A PHOTOGUIDE AND THE INTERNET

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Clinical Outcomes in Schizophrenia Treated with Donepezil in Combination with Antipsychotics

    Nov 1, 2013, 00:00

  • Grade for Quality Assessment of Efficacy and Effectiveness Studies on Anti-TNFs Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Systematic Review on Use of Economic Evidence by Clinical Guidelines

    Nov 1, 2013, 00:00

  • Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada

    Nov 1, 2013, 00:00

  • Delay of Total Hip Replacement (THR) Using HA Viscosupplementation- Is Cost Effective?

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis

    Nov 1, 2013, 00:00

  • The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United Kingdom

    Nov 1, 2013, 00:00

  • Comparative Costs Analysis of Conventional Strategy Versus Step-Down Strategy with Linezolid in the Treatment of Nosocomial Pneumonia Caused by Gram Positive Bacteria in Mexico

    Nov 1, 2013, 00:00

  • Cross (-Walk) at Your Own Peril! Comparing and Contrasting Cea Results When Individual-Level Utilities Are Derived from External Mapping Algorithms Rather Than Actually Observed Responses

    Nov 1, 2013, 00:00

  • Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications

    Nov 1, 2013, 00:00

  • Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)

    Nov 1, 2013, 00:00

  • Application of a Data Visualization Tool- Treatment Patterns of Veteran Patients with Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Eliciting Patients’ Preferences for Epilepsy Diagnostics- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Permanent Transvenous Lead Extraction- Factors Influencing the Difficulty of the Procedure

    Nov 1, 2013, 00:00

  • Patterns of Use of Tests to Diagnose and Assess Disease Progression in Multiple Sclerosis (MS)- A Multicountry Comparison

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2013, 00:00

  • Uncovering the Gap Between Model Validation Recommendations and Practice

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ivabradine Use in Belarus

    Nov 1, 2013, 00:00

  • Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III Trial

    Nov 1, 2013, 00:00

  • How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors

    Nov 1, 2013, 00:00

  • Australian Standard Costs and Consequences of Four Chemotherapy Adverse Events

    Nov 1, 2013, 00:00

  • Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in Germany

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with the Hepatitis C Virus in the United States

    Nov 1, 2013, 00:00

  • Exploring Gender Differences in Population-Based Prevalences of Cardiovascular Diseases in Chile After the Health Care Reform of 2005

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Adult Type 1 Diabetes in Kazakhstan

    Nov 1, 2013, 00:00

  • Assessment and Causal Link Between Vision-Related Quality of Life and General Health Related Quality of Life in Dry Eye Patients

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in Russia

    Nov 1, 2013, 00:00

  • A Review of Cost-Effectiveness Evaluations as Part of National HTA Assessments of Biologic Dmards in the Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom

    Nov 1, 2013, 00:00

  • Illustration of the Combined Effect of Patient’s Adherence and Individual Biological Characteristics on Blood Pressure

    Nov 1, 2013, 00:00

  • Web-Based of Topic Selection for Comparative Effectiveness Research in Korea

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Hepatitis C in Children and Young People

    Nov 1, 2013, 00:00

  • Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan

    Nov 1, 2013, 00:00

  • Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected Studies

    Nov 1, 2013, 00:00

  • Analysis of Total Treatment Costs of Organophosphorous Poisoning in a Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • The Influence of Choice Task Layout on the Outcomes of a Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Factors Associated with Poor Adherence in Patients Initiating Medication for Major Depressive Disorder- Interim Results from a Prospective, Longitudinal Study

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Model Comparing Sub-Cutaneous Biologic Treatment for Severe Plaque Psoriasis in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina

    Nov 1, 2013, 00:00

  • Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)- A Tool to Position New Treatments in the Patient Pathway?

    Nov 1, 2013, 00:00

  • Towards Evidence-Based European Policy in Clinical Trials the Survey of Attitudes Towards Trial Sites in Europe - The SAT-EU StudyTm

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Venous Thromboemoblism- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Biosimilar and Originator Biologic Pricing Dynamics in Emerging Markets

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Combined Treatment of Metformin and Fenofibrate on Retinopathy Progression

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Dl Tratamiento Profiláctico Versus a Demanda En Adultos Jóvenes Con Hemofilia a Severa En Colombia

    Nov 1, 2013, 00:00

  • Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States

    Nov 1, 2013, 00:00

  • The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in Spain

    Nov 1, 2013, 00:00

  • Economic Evaluation of Direct Acting Antiviral (DAA) Treatments for Hepatitis C Virus (HCV) Infection in Previously Treated Patients from the Peruvian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Comparación Del Trabajo En Equipo En Salas De Cirugía Entre Un Hospital Privado Y Uno Público De Bogotá, D.C

    Nov 1, 2013, 00:00

  • Results of a Study Using a Tablet PC to Collect PROs in Elderly Population

    Nov 1, 2013, 00:00

  • Multi-Dimensional Capture of Patient-Relevant Endpoints in Regulatory Trials and Health Technology Assessments in Oncology Two Years After Introduction of the German Amnog Health Care Reform

    Nov 1, 2013, 00:00

  • Payer Assessment and Reimbursement Policy for Rare Diseases- A Review of the Literature

    Nov 1, 2013, 00:00

  • Medical Cards During Recession- How Many, for Whom and How Much?

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece

    Nov 1, 2013, 00:00

  • Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?

    Nov 1, 2013, 00:00

  • The Health of Health Technology Assessment in Ireland- Five Points for Improvement

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

    Nov 1, 2013, 00:00

  • Feasibility of Use of Medical Transcription Data for Real World Evidence Generation in the United States- A Pilot Study of Patients with Systemic Lupus Erythematosus Initiated on Belimumab

    Nov 1, 2013, 00:00

  • Economic Impact of Pruritus Among End-Stage Renal Disease Patients Receiving Hemodialysis

    Nov 1, 2013, 00:00

  • Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Comparison of Genotype 1 Hepatitis C Virus (HCV) Treatments Using Telaprevir (TVR) in Patients with Mild Fibrosis Versus Patients with Bridging Fibrosis and Cirrhosis

    Nov 1, 2013, 00:00

  • The Development and Validation of a Quality of Life Measure for People with Mild Cognitive Impairment (The MCQ)

    Nov 1, 2013, 00:00

  • The Potential Cost-Effectiveness of Obinutuzumab (Ga101) in Combination with Chlorambucil in Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • Comparison of Disease Status, Treatments and Outcomes of Patients with Psoriatic Arthritis Receiving Their First Biologic in the European Union and United States

    Nov 1, 2013, 00:00

  • Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?

    Nov 1, 2013, 00:00

  • Decison Making Under Uncertainty- Coverage with Evidence Development in the Context of Medical Devices

    Nov 1, 2013, 00:00

  • A Review of Methods Used in Health Economic Models of Chronic Myeloid Leukemia Interventions

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Brazil- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Resources Saved by the Introduction of Day Surgery in the Greek National Health System

    Nov 1, 2013, 00:00

  • Efficacy of Inhaled Antibiotics in CF Patients with Chronic P. Aeruginosa Infection- A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Oral Hypoglycaemic Medicine (OHM) Initiation in Newly Treated Type 2 Diabetes Mellitus (T2DM) in Ireland- An Analysis of Treatment Intensification and Switching Patterns

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States

    Nov 1, 2013, 00:00

  • Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIV

    Nov 1, 2013, 00:00

  • Adherence to Warfarin Treatment in Brazil- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • Market Access of Implantable Medical Devices- Evidentiary Requirements Across Global Markets

    Nov 1, 2013, 00:00

  • Dynamic Modeling of Vector-Borne Diseases (VBD)- The Example of Malaria

    Nov 1, 2013, 00:00

  • Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients- A French National Claims Database Analysis Over the Period 2009-2011

    Nov 1, 2013, 00:00

  • Amnog Benefit Assessment- Time Delay of Market Access for Pharmaceuticals in Germany?

    Nov 1, 2013, 00:00

  • Assessment of the Budgetary Impact of Improving the Use of Evidence-Based Medicine in the Treatment of Patients with Heart Failure and Left Ventricular Dysfunction in England

    Nov 1, 2013, 00:00

  • Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases

    Nov 1, 2013, 00:00

  • Patients with Hypertension in Primary Care in Spain- Management, Self-Perception and Satisfaction

    Nov 1, 2013, 00:00

  • Probabilistic Sensitivity Analysis to Analyze the Cost-Effectiveness of Oral Hypoglycemic Agents in the Initial Oral Drug Treatment of Outpatients Diagnosed with Type 2 Diabetes in Primary Care

    Nov 1, 2013, 00:00

  • Clinical, Epidemiological and Economic Metrics Difference Between HPV-Related and Traditional Head and Neck Cancers

    Nov 1, 2013, 00:00

  • Methodology for Establishing Internal and External Validity When Propensity Score Matching Is Used

    Nov 1, 2013, 00:00

  • Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

    Nov 1, 2013, 00:00

  • Pricing of “Follow-On” Drugs and Competition Within Pharmaceutical Classes- Evidence from Germany 1993-2008

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Intravitreal Aflibercept (IVT-AFL) for Neovascular Age-Related Macular Degeneration in Spain

    Nov 1, 2013, 00:00

  • What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France?

    Nov 1, 2013, 00:00

  • Comparing Costs and Consequences of Treating Chronic Obstructive Pulmonary Disease with Budesonide/Formoterol and Fluticasone/Salmeterol

    Nov 1, 2013, 00:00

  • Comparisons of the Risk for Venous Thromboembolism Between Hip and Knee Arthroplasty Using Korea National Health Insurance Claims Database

    Nov 1, 2013, 00:00

  • Economic and Quality-Of-Life Burden of Moderate to Severe Irritable Bowel Syndrome with Constipation (IBS-C) in Spain- Interim Analysis of the IBIS-C Study

    Nov 1, 2013, 00:00

  • Cost-Per-Responder Analysis of Biological Agents for the Treatment of Active Ankylosing Spondylitis in Germany

    Nov 1, 2013, 00:00

  • Budget Impact of Switching from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus in Renal Transplant Recipients in the UK Based on Differences in Adherence

    Nov 1, 2013, 00:00

  • Understanding Patterns of Monitoring of Appropriate Prescribing in Europe

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries

    Nov 1, 2013, 00:00

  • Editorial Board

    Nov 1, 2013, 00:00

  • Systematic Review Comparing the Efficacy and Safety of Collagenase Clostridium Histolyticum (Xiaflex®) Injection with Surgical Fasciectomy for the Treatment of Dupuytren’s Contracture

    Nov 1, 2013, 00:00

  • Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)

    Nov 1, 2013, 00:00

  • Orphan Drug Access- Risk/Reward Analysis of Local Clinical Development in Chile

    Nov 1, 2013, 00:00

  • Estimation of the Cost of Complications Related to Glycated Hemoglobin in the Italian Diabetes Type 1 Population

    Nov 1, 2013, 00:00

  • Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany

    Nov 1, 2013, 00:00

  • Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation

    Nov 1, 2013, 00:00

  • Indirect Comparison of Joint Damage Prevention with Adalimumab V. Abatacept, Each in Combination with Methotrexate, in Early Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Cost-effectiveness Analysis in the Treatment of Heavy Menstrual Bleeding in Spain

    Nov 1, 2013, 00:00

  • Direct Medical Costs of Treating Diabetes-Related Complications in Argentina

    Nov 1, 2013, 00:00

  • Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Patient-Level Markov Model to Assess Economic Impact of New Antipsychotics Introduction in Schizophrenia

    Nov 1, 2013, 00:00

  • The Minimal Important Decrease of Health Utility in Living Kidney Donors

    Nov 1, 2013, 00:00

  • Health and Social Care Resource Use by Individuals with Fragile X Syndrome- Results of Two Delphi Panels

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab in Rheumatoid Arthritis, in Colombia

    Nov 1, 2013, 00:00

  • Public Preference Elicitation in Drug Reimbursement Using Multi-Criteria Decision Analysis (MCDA) for Universal Health Insurance System in South Korea

    Nov 1, 2013, 00:00

  • Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan

    Nov 1, 2013, 00:00

  • Health Economic Analyses in Medical Nutrition- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of Patient Perception of Arrhythmia Questionnaire in Poland

    Nov 1, 2013, 00:00

  • Estimating Chronic Disease PREVALENCE from Claims Data- Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept in Treating Neovascular Age-Related Macular Degeneration in Sweden

    Nov 1, 2013, 00:00

  • Using Feedback from Patients in Determining Suitability of the Perceived Deficits Questionnaire (PDQ) and the Resource Utilization in Dementia-Lite (RUD-Lite) for Use in Clinical Trials in Prodromal Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • Impact of Cardiovascular Disease on Labour Force Participation- Bivariate Probit Analysis

    Nov 1, 2013, 00:00

  • Overcoming the HTA Hurdle in Germany- Key Considerations for a Manufacturer’s Pricing and Market Access Strategy

    Nov 1, 2013, 00:00

  • Comparison of Development Diagnosis Related Groups Base Rate in Hungary and Germany

    Nov 1, 2013, 00:00

  • Study and Evaluation of Medication Errors in Diabetic Patients in Medicine Ward of a Secondary Care Community Hospital at Mumbai, India

    Nov 1, 2013, 00:00

  • Economic Evaluation of HPV Vaccination Program in South Korea

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biologic Drugs for Treatment of Poliarticular Juvenile Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs Program

    Nov 1, 2013, 00:00

  • Variabilidade No Tratamento Do Cancer De Mama No Brasil

    Nov 1, 2013, 00:00

  • Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?

    Nov 1, 2013, 00:00

  • A Methodology for Predicting the Impact of Copayments on the Utilization of Health Technologies

    Nov 1, 2013, 00:00

  • Desarrollo De Una Escala De Estructuras Y Proceso Para La Evaluación De Los Centros De Hemodiálisis

    Nov 1, 2013, 00:00

  • Treatment Patterns for Parkinson’s Disease- Real-World Evidence from the EU5 (France, Germany, Italy, Spain, and the United Kingdom)

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2013, 00:00

  • Waiting Times and Scheduling in Dermatological Practices in Germany

    Nov 1, 2013, 00:00

  • Atrial Fibrillation’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Gastroesophageal Reflux Disease in Slovakia

    Nov 1, 2013, 00:00

  • Use of Antenatal Corticosteroids Lowers Hospitalization Costs Related to Prematurity

    Nov 1, 2013, 00:00

  • Evolução Do Uso De Medicamentos Genéricos No Tratamento De Doenças Crônicas – Pbm Brasileira

    Nov 1, 2013, 00:00

  • Cost Per Cure of Telaprevir and Boceprevir in Treatment-Naïve Genotype 1 Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone- A Cost-Effectiveness Analysis from the Perspective of the Italian Health System

    Nov 1, 2013, 00:00

  • The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil

    Nov 1, 2013, 00:00

  • How Hypoglycemia Impacts Quality of Life and Treatment Satisfaction in Type 2 Diabetes Mellitus Patients on Basal-Bolus Insulin Therapy?

    Nov 1, 2013, 00:00

  • Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

    Nov 1, 2013, 00:00

  • Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

    Nov 1, 2013, 00:00

  • Time Dependent Resource Use and Costs Associated with Different States of Disease in Patients Diagnosed with HER-2 Positive Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Which Are the Attitudes of Primary Health Services Users Concerning Cost Sharing Measures in a Period of Economic Crisis in Greece?

    Nov 1, 2013, 00:00

  • Frecuencia Y Costos De Hospitalización En Una Población De Pacientes En Dialisis En Colombia

    Nov 1, 2013, 00:00

  • The Relationship Between COPD Assessment Test (CAT) and EQ-5D in a Real World Patient Population

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Cintas De Uretra Media Comparadas Con El Tratamiento Convencional De La Incontinencia Urinaria Femenina De Esfuerzo En Colombia

    Nov 1, 2013, 00:00

  • The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality- An Ecological Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone Deficiency

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Empiric Liposomal Amphotericin B Versus Voriconazole in Turkey

    Nov 1, 2013, 00:00

  • Orphan Drug Legislations- Heyday or Had Their Day?

    Nov 1, 2013, 00:00

  • Exploratory Structural Equation Models- A Simulation Study Exploring Geomin and Target Rotation Techniques on Variations of ESEM Models

    Nov 1, 2013, 00:00

  • The Expanding Scope of Comparative Effectiveness Reviews Requires Collaborative Information Systems Solutions

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer

    Nov 1, 2013, 00:00

  • Divergence of HTA Decisions Across Countries- Case Analysis of Ivabradine

    Nov 1, 2013, 00:00

  • Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United States

    Nov 1, 2013, 00:00

  • Potential Financial Impact of Sugammadex in Anaesthetic Departments- A Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade

    Nov 1, 2013, 00:00

  • Audit of the Coverage Decision-Making Process in a Government Agency in Uruguay- From the Guidelines Till the Patients

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Apixaban for the Prevention of Venous Thrombo-Embolism in Patients Undergoing Orthopedic Replacement Surgery in Italy

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Diferent Anti-Parkinsonian Drugs Used in Monopherapy During Early Stages of Parkinson Disease

    Nov 1, 2013, 00:00

  • A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical Trails

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Conservative Therapy Versus Cystectomy for Non-Muscle Invasive Bladder Cancer Patients

    Nov 1, 2013, 00:00

  • Estimating the Health Outcome of Treating Type 2 Diabetic Population to Target in Local Municipality Level

    Nov 1, 2013, 00:00

  • Evaluation of Home Medication Review in Community Out Reach Program

    Nov 1, 2013, 00:00

  • Análise Das Potencialidades De Custo-Minimização Através Da Determinação Do Market Share Entre Os Quimioterápicos De Referência Que Possuem Genéricos Cadastrados Em Uma Operadora De Plano De Saúde

    Nov 1, 2013, 00:00

  • Epidemiology and Economic Studies on Patients Diagnosed with Insomnia- A Review of the Literature

    Nov 1, 2013, 00:00

  • Analysis of Transparency Amongst International Health Technology Assessment Organizations

    Nov 1, 2013, 00:00

  • Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Periodic Safety Update Reports (PSURS) for Biologicals in Europe

    Nov 1, 2013, 00:00

  • Effects of Excess Use of Coronary Angiography and Its Association with Mortality Rates, Health Care Costs and Hospital Quality in Turkey

    Nov 1, 2013, 00:00

  • Clinical Outcomes and Health Care Costs Evaluation of Sulfonamides and Thiazolidinediones Compared with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Uncontrolled Diabetes

    Nov 1, 2013, 00:00

  • Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index” En Pacientes Con Psoriasis- Una Revisión Sistemática

    Nov 1, 2013, 00:00

  • Use of Real-World Evidence (RWE) to Validate a Trial-based Health Economic Model

    Nov 1, 2013, 00:00

  • Are Generic Drugs Defined and Classified Consistently Around the World?

    Nov 1, 2013, 00:00

  • Health Technology Assessment Report for Positron Emission Tomography in Patients with Cancer

    Nov 1, 2013, 00:00

  • Building a Real World Practice-Based Network Data Platform to Link Rare Disease Patients- Case Study of Myelofibrosis Patients in the United States

    Nov 1, 2013, 00:00

  • Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil- A Public Perspective Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke- An Analysis of Patients with Atrial Fibrillation in Greece

    Nov 1, 2013, 00:00

  • The Patient-Reported Outcomes Measurement Information System in Spanish

    Nov 1, 2013, 00:00

  • IQWIG’s Efficiency Frontier Approach- Fit for Purpose!

    Nov 1, 2013, 00:00

  • Análisis Bibliométrico De La Producción Científica En Economía De La Salud En Latinoamérica

    Nov 1, 2013, 00:00

  • Affordability of Antihypertensive Treatment in Mexico

    Nov 1, 2013, 00:00

  • Associations Between Overall Care Experience Ratings and Utility and Psychological Well-Being in Men Recently Diagnosed with Prostate Cancer- Findings from a Population-Based Study

    Nov 1, 2013, 00:00

  • Estudio Transversal Del Proceso De Actualización De Medicamentos En El Cuadro Básico Y Catálogo De Insumos Del Sector Salud

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Clopidogrel Versus Ticagrelor, Ambos En Combinación Con Asa, Para El Manejo Del Síndrome Coronario Agudo, Desde La Perspectiva Del Sistema De Salud Privado En México

    Nov 1, 2013, 00:00

  • A Cost–Effectiveness And Budget Impact Analysis of Different Biologic Treatments for Psoriasis in Colombia

    Nov 1, 2013, 00:00

  • How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) and Resources Consumption in Insulin-Dependent Diabetic Patients with A1CNOW+ and CONTOUR USB. Comet Study

    Nov 1, 2013, 00:00

  • Prevalence of Comorbidities Among Chronic COPD Patients in the United States

    Nov 1, 2013, 00:00

  • An Analysis of Priscription and Reimbursement of Potentially Inappropriate Medication (PIM) in a German Practice Network

    Nov 1, 2013, 00:00

  • Estimating the Budget Implications of Radium Ra 223 Dichloride in Castration-Resistant Prostate Cancer Patients with Non-Visceral Bone Metastases Treated in Infusion Centers in the United States

    Nov 1, 2013, 00:00

  • Challenges of Conducting Economic Evaluations Using Linked Electronic Health Records - CPRD and HES in the United Kingdom

    Nov 1, 2013, 00:00

  • Point of Care Tests- The Long and Winding Road to Reimbursement

    Nov 1, 2013, 00:00

  • Cost and Cost-Effectiveness Analyses for Moderate and Severe COPD Patients Treated Uniquely with Tiotropium 18 Mcg Od for Twenty-Four Months

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Colombia

    Nov 1, 2013, 00:00

  • Experiencia Inicial Con Un Nuevo Tipo De Documento De Evaluación De Tecnología Sanitaria- “Informes De Mesa De Ayuda”

    Nov 1, 2013, 00:00

  • Peritonitis Fluid Treatment in Russian Federation- Evaluation of Economical Burden in Real Clinical Practice

    Nov 1, 2013, 00:00

  • Risk of Psychiatric and Neurological Diseases in Patients with Workspace Mobbing Experience in Germany- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Obesity Trends 2006-2012 in the United States- Results from the National Health and Wellness Survey

    Nov 1, 2013, 00:00

  • Ánalise De Significância Do Banco De Dados De Hospitais Particulares Brasileiro

    Nov 1, 2013, 00:00

  • Determinants of Non-Adherence to Medications Among Chronic Patients in Maccabi Health Care Services

    Nov 1, 2013, 00:00

  • Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • A Nationwide Survey on Patient Safety Culture in Japan

    Nov 1, 2013, 00:00

  • Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia

    Nov 1, 2013, 00:00

  • Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Capsule Endoscopy (Pillcam®) in the Diagnosis of Small Bowel Crohn’s Disease

    Nov 1, 2013, 00:00

  • One Line Does Not Make a Picture- Real-World Cost-Effectiveness of Multiple Myeloma Treatments Using a Full Disease Model

    Nov 1, 2013, 00:00

  • Integración De Un Marco Conceptual Para La Evaluación De La Calidad De Servicios Farmacéuticos Hospitalarios Enfocados a La Mejora De La Farmacoterapia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Systematic Identification and Treatment of Comorbid Major Depression for People with Chronic Diseases- The Example of Cancer

    Nov 1, 2013, 00:00

  • Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2013, 00:00

  • The Relative Efficacy and Safety of Simeprevir and Telaprevir in Treatment-Naïve Hepatitis C Infected Patients in a Japanese Population – A Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Development of the Scharr HUD (Health Utilities Database)

    Nov 1, 2013, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (MM) Patients- Update of a Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2013, 00:00

  • Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)

    Nov 1, 2013, 00:00

  • Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • ISPOR 4th Latin America Conference Disclosure Information

    Nov 1, 2013, 00:00

  • Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians- Findings from a Routine Practice Study in 13 Medium-Sized European Countries

    Nov 1, 2013, 00:00

  • Resultados De La Encuesta “Change Pain” Latinoamericana- Diagnostico Y Tratamiento Actual De Los Pacientes Con Dolor Crónico

    Nov 1, 2013, 00:00

  • Mixed Treatment Comparison of Adverse Events for BG-12, Glatiramer, and Teriflunomide for the Treatment of Relapsing Forms of Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQoL) in Patients Treated by Novel Oral Anticoagulants (NOACs)- Reduced Version of the Sawicki Questionnaire

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in India

    Nov 1, 2013, 00:00

  • Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year

    Nov 1, 2013, 00:00

  • Added Value and Future Adoption of a New Medical Imaging Technology for Interventional Cardiology

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil

    Nov 1, 2013, 00:00

  • Effect of Nurse-Led Medication Reviews in Psychiatric Patients – An Interventional Study

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Pharmacogenetic Screening Prior to Initiation of Carbamazepine Treatment for Epilepsy

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • Predictors of Costs of Antiretrovirals for HIV Infection in Italy- A Multicentric Retrospection in 2012

    Nov 1, 2013, 00:00

  • Reaching the Middle of the Pyramid- Implications for the PMA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Different Antiviral Therapies in the Treatment of Russian Patients with Chronic Hepatitis C

    Nov 1, 2013, 00:00

  • The Financial Impact of Increasing Home-Based High Dose Haemodialysis and Peritoneal Dialysis

    Nov 1, 2013, 00:00

  • Does HTA Process Help to Achieve the Health Objectives of the Millennium? A South American Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of the Impact of New Treatment Alternatives on Market Dynamics in Respiratory Diseases; A Case Study in Turkish Health Care System

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Prepex Device and Dorsal–Slit Technique for Scaling-Up Adult Safe Medical Male Circumcision in HIV Prevention in Rural Central Uganda

    Nov 1, 2013, 00:00

  • Budget Impact and Thresholds- How Are Real Decisions Made? - Expected Utility or Prospect Theory?

    Nov 1, 2013, 00:00

  • Reliability and Validity of a Thai Version of Lam Employment Absence and Productivity Scale (LEAPS)

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Intervenciones Preventivas Contra El Cáncer De Cuello Uterino En Mujeres Peruanas

    Nov 1, 2013, 00:00

  • An Economic Evaluation Alongside a Clinical Trial (EEACT) in Pelvic Floor Medicine

    Nov 1, 2013, 00:00

  • Enteral Diets (ED)- A Cost-Comparison Analysis for In-Hospital Preparations Based on Real World Observation

    Nov 1, 2013, 00:00

  • Are Monoclonal Antibodies Still Considered as Innovative by the French Health Care System? A Retrospective Analysis 2000-2012

    Nov 1, 2013, 00:00

  • Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis- The Role of the Patient-Reported Outcome Consortium’s RA Working Group

    Nov 1, 2013, 00:00

  • Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care System

    Nov 1, 2013, 00:00

  • Juggling Jurisdictions- Methods for Conducting Modular Systematic Reviews?

    Nov 1, 2013, 00:00

  • Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)

    Nov 1, 2013, 00:00

  • Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly Patients

    Nov 1, 2013, 00:00

  • Preliminary Results Quality of Life, Physical Activity, and Sedentary Behavior in College Students

    Nov 1, 2013, 00:00

  • Modelling the Relationship Between the WOMAC Osteoarthritis Index and EQ-5D

    Nov 1, 2013, 00:00

  • Health Economic Evidence for Medical Nutritions- Are These Interventions Value for Money?

    Nov 1, 2013, 00:00

  • Patient-Centered Outcomes in Upper Limb Spasticity- Results from a Large International Cohort Study (ULIS-2)

    Nov 1, 2013, 00:00

  • Costs Evaluations of Ready-To-Use Propofol Syringes Versus Syringes Drawn from Vials in Critically Ill

    Nov 1, 2013, 00:00

  • Needs Assessment of Patients Treated in Community Psychosocial Centers in São Paulo, Brazil

    Nov 1, 2013, 00:00

  • High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting- Treatment Patterns and Outcomes

    Nov 1, 2013, 00:00

  • The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland

    Nov 1, 2013, 00:00

  • The Relationship Between Submitted Line of Therapy and Reimbursement Decisions in Solid State Tumor Cancer Drugs

    Nov 1, 2013, 00:00

  • Hospital Resource Use in Chronic Disease Combinations- Is It Enough to Just Add Them Up?

    Nov 1, 2013, 00:00

  • A Parent-Administered But Child-Completed Patient-Reported Outcome (PRO) Provides a Measure with Content Validity That Is Valid and Reliable for Use in Children Aged 6 to 11 Years

    Nov 1, 2013, 00:00

  • Economic Burden of Coronary Heart Disease in the Patients Attending National Heart Center, Kathmandu, Nepal

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De Dos Tratamientos Farmacológicos En Degeneración Macular Relacionada Con La Edad De Tipo Exudativa (Dmre) Para Venezuela

    Nov 1, 2013, 00:00

  • The Burden of Pneumonia in Malaysia, Indonesia and Philippines

    Nov 1, 2013, 00:00

  • Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Caregiver Burden in Fragile X Syndrome as a Function of a Health State Utility Index in the United States

    Nov 1, 2013, 00:00

  • The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-Forms

    Nov 1, 2013, 00:00

  • Cost of Microvascular and Macrovascular Complications in Peoples with Diabetes Type 1 and Type 2 in Bulgaria

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En Colombia

    Nov 1, 2013, 00:00

  • Children with Atopic Dermatitis- Monitoring a French Cohort Over a Nine-Year Period

    Nov 1, 2013, 00:00

  • Advanced Budget Notification (ABN)- Is There a Win-Win for Manufacturers and Payers Given the Current Austerity Measures Across the EU

    Nov 1, 2013, 00:00

  • Resource Use and Cost of Diagnosis and Management of Breast Cancer by Stage in an Irish Teaching Hospital

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of a New Fixed-Dose Combination Inhaler for a Clinical Commissioning Group within the National Health Service in England

    Nov 1, 2013, 00:00

  • Market Access of Cancer Drugs in European Countries- A Matter of Setting Priorities for Resource Allocation

    Nov 1, 2013, 00:00

  • The Burden of Illness of Pulmonary Arterial Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Association Between Non-Motor Symptoms and Health Care Utilization Among Patients with Parkinson’s Disease in the United States

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Electrical Impedance Spectroscopy (EIS) Device Used as an Adjunct to Colposcopy

    Nov 1, 2013, 00:00

  • Direct Cost of Diabetes Mellitus and Its Complications in Spain. Seccaid Study- Spain Estimated Cost Ciberdem-Cabimer in Diabetes

    Nov 1, 2013, 00:00

  • Pulse Pressure and Stroke Risk- Development and Validation of a Stroke Risk Equation

    Nov 1, 2013, 00:00

  • Burden of Disease of Cervical Dystonia in the United Kingdom

    Nov 1, 2013, 00:00

  • Análisis Costo-Utilidad De Dos Alternativas Para El Tratamiento De Bebés Prematuros En Bogotá

    Nov 1, 2013, 00:00

  • Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries- THE Results of the Literature Review

    Nov 1, 2013, 00:00

  • Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation- A Markov Model

    Nov 1, 2013, 00:00

  • Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012)

    Nov 1, 2013, 00:00

  • Mapping the Oxford Hip Score (OHS) to EQ-5D- A Test of Model Performance

    Nov 1, 2013, 00:00

  • Design of a Randomized Controlled Trial (RCT) Evaluating Outcome and Cost-Effectiveness of a Local Case Management Intervention of Patients Suffering from Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • The Budget Impact Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in Children and Adolescents (Age ≤18 Years)

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in Germany

    Nov 1, 2013, 00:00

  • There Is More to Decision Making Than Costs and Effects- Handling Practical Constraints in the Value of Information Framework

    Nov 1, 2013, 00:00

  • Examining the Effects of a Functional Restoration and Pain Management Program Among Chronic Pain Patients in the Texas Workers Compensation System- Pilot Study – Part I

    Nov 1, 2013, 00:00

  • Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health Disparities

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients- An Analysis with the Quebec (Canada) Public Drug Plan Database

    Nov 1, 2013, 00:00

  • Symptoms of COPD in Urban Russia Among Adults 40 Years and Older

    Nov 1, 2013, 00:00

  • Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations- Results from Patients in the Quest-1, Quest-2, and Pro ...

    Nov 1, 2013, 00:00

  • Treatment Satisfaction and Its Association with Health Outcomes in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus Erythematosus

    Nov 1, 2013, 00:00

  • Value Chain Analysis for Cardiac Devices

    Nov 1, 2013, 00:00

  • Patients’ and Caregivers’ Preferences for Bone Metastases (BM) Treatments in the United States

    Nov 1, 2013, 00:00

  • Variances in Individuals’ Prescription Drug Costs in Ireland

    Nov 1, 2013, 00:00

  • Impact of Medication Adherence on Health Care Cost in COPD

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia

    Nov 1, 2013, 00:00

  • Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in Greece

    Nov 1, 2013, 00:00

  • Investigating the Value of Abatacept IV in the Treatment of Rheumatoid Arthritis- A Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch Analysis

    Nov 1, 2013, 00:00

  • Disease Becomes Social. Health Research Conducted On, or Using, Web 2.0 Media- A Systematic Review

    Nov 1, 2013, 00:00

  • Additional Clinical Benefit for Patient Relevant Endpoints- Investment Disincentives by AMNOG in the Example of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Análisis De Minimización De Costos Del Uso Del Aflibercept En Degeneracion Macular Relacionada Con La Edad En Colombia

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Tres Estrategias Diagnosticas Para La Identificación De Infección Bacteriana Severa En Lactantes Febriles Sin Foco

    Nov 1, 2013, 00:00

  • Review of Nice Technology Appraisals in Oncology- How Does Clinical Evidence Change Over Time?

    Nov 1, 2013, 00:00

  • Patient Preferences on Treatments for Erectil Dysfunction Defined by Means of Different Attribute Groups- The Method of Administration Is the Most Valued Attribute and the Orodispersible Tablet Is the Most Preferred Level

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

    Nov 1, 2013, 00:00

  • Comparing the Health Care Costs and Utilizations Between Patients with Anxiety Versus Those Without

    Nov 1, 2013, 00:00

  • Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab- Model Based Analysis

    Nov 1, 2013, 00:00

  • Are “Dizzy” and “Lightheaded” the Same Concept or Separate Concepts? Challenges in Conceptual Equivalence of These Terms in 20 Languages

    Nov 1, 2013, 00:00

  • Patient Preference for Oral Versus Injectable and Intravenous Methods of Treatment for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease in France in 2011

    Nov 1, 2013, 00:00

  • Validación De Un Cuestionario Para Medir Riesgo De Cáncer De Piel

    Nov 1, 2013, 00:00

  • Points to Consider in Multiregional Trials Using PHQ-9- A Meta-Analysis on PHQ-9

    Nov 1, 2013, 00:00

  • Variations in Treatment Patterns and Disease Severity Among Patients with Psoriasis Receiving Their First Biologic in European Union

    Nov 1, 2013, 00:00

  • Boceprevir Use in Fran A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)

    Nov 1, 2013, 00:00

  • A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Lines

    Nov 1, 2013, 00:00

  • The Burden of Illness of Chronic Thromboembolic Pulmonary Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Estimating the Impact of Endogenous Substance Abuse on Self-Reported Health Status

    Nov 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105 (current)
  • 106
  • 107
  • 108
  • 109
  • 110
  • »